Concurrent Durvalumab And Radiation Therapy (DUART) followed by Adjuvant Durvalumab in Patients with Localized Urothelial Cancer of Bladder: BTCRC-GU15-023.

Authors :: Joshi, M.
Zakharia, Y.
Kaag, M.
Kilari, D.
Holder, S.
Emamekhoo, H.
Sankin, A.
Liao, J.
Merrill, S.
DeGraff, D.
Zheng, H.
Warrick, J.
Hauke, R.
Gartrell, B.
Stein, M.
Drabick, J.
Tuanquin, L.C.
Source :: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pS29-S30. 2p.
Publication Year :: 2020

Subjects :: *TRANSITIONAL cell carcinoma
*BLADDER cancer
*RADIOTHERAPY
*ONCOLOGISTS

Full Text Access

Tools